companydata.dkcompanydata.dk

ORIFARM A/S: Financial statements 2016

CVR: 26058708

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

ORIFARM A/S (CVR 26058708) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 1,202,590,000 and a net result of DKK 3,640,000 compared with DKK 5,442,000 the year before. That is an increase of 16.2% compared with the year before. The profit margin was 0.3%. Equity in the 2016 report amounted to DKK 31,874,000. The solvency ratio was 10.2%. The company had 72 employees in the financial year.

Revenue
DKK 1,202,590,000
Gross Profit
DKK 58,027,000
Profit/Loss
DKK 3,640,000
Equity
DKK 31,874,000
Total Assets
DKK 312,438,000
Employees
72

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20161.2 mia.58 mio.3.6 mio.31.9 mio.72
20151 mia.52.2 mio.5.4 mio.28.2 mio.-
20141.1 mia.46.8 mio.4.4 mio.22.8 mio.-
20131.1 mia.42.2 mio.4.5 mio.18.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ORIFARM A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

ORIFARM A/S: The 2015 annual report is outJun 3, 2016

ORIFARM A/S has published its annual report for 2015. Revenue came to DKK 1,035,134,000, and the net result was DKK 5,442,000.

About ORIFARM A/S

ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.

Source: annual report 2025, Danish Business Authority